DRUG DISCOVERY – Groundbreaking Technology: Shorten wet-bench experimental time and reduce animal use in drug discovery research

DRUG DISCOVERY – Groundbreaking Technology: Shorten wet-bench experimental time and reduce animal use in drug discovery research

This webinar has already taken place. However, you can watch a recording of it below.
Originally aired on September 10th, 2015

The Signature Square program has been designed by the industry, for the industry.

It is your opportunity to evaluate and provide feedback on an exclusive, one-of-a-kind technology that has the potential to shorten wet-bench experimental time and reduce animal use in drug discovery research by mimicking the physiological conditions of the human body.

This exclusive opportunity provides you with a front-row seat to hear about new technology and science. Current member companies in the Signature Square program include organizations like Pfizer, AbbVie, Amgen and Janssen, along with many others.

However, on a trial basis, we are allowing new industry participants, and other scientists, clinicians & organizations, to evaluate this technology and take part in this webinar entitled “DRUG DISCOVERY – Groundbreaking Technology: Shorten the wet-bench experimental time and reduce animal use in drug discovery research” on Thursday, September 10th at 11am EST.

GelCel is a cell culture system which can mimic the micro-scale physiological conditions of the body. Scientists work with model systems that are meant to be small-scale versions of the real-life conditions in the body. However, many scientists work on micro-level models with cells using plastic-based culture containers which are far from the natural environment of the body.  

GelCel can replace cell culture flasks, without any change to current protocols for the cell culture, and will provide results that are comparable to physiological conditions. This innovative technology will also lead to a decrease in the need for animal models; it saves time versus hydrogel-based cell culture because of the significant increase (at least 4 times higher) in the surface area for cell harvest; and, most importantly, it will provide for the culture of primary cells acquired from any tissue of the body, as well as for stem cells.

By attending, you will have the opportunity to listen to a presentation on the technology, ask questions, and evaluate the technology (anonymously).

 

PANELISTS
	SPEAKER: Dr. Kaori Ihida-Stansbury Research Assistant Professor University of Pennsylvania
	MODERATOR: Dawn Van Dam President & CEO One Million Solutions in Health™